COVID-19 vaccine booster, Immunogenicity, Safety, Omicron, mRNA vaccine, Pandemic preparedness, Vaccine equity, Neutralizing antibody, T-cells
SARS-CoV-2 vaccine, booster dose, neutralizing antibody titer, anti-SARS-CoV-2 IgG, CoronaVac vaccine, ChAdOx1 nCoV-19 vaccine, AZD1222